The estimated Net Worth of Melanie J Herman is at least 482 千$ dollars as of 18 May 2016. Melanie Herman owns over 334 units of Ligand Pharmaceuticals stock worth over 339,888$ and over the last 10 years Melanie sold LGND stock worth over 142,462$.
Melanie has made over 9 trades of the Ligand Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently Melanie sold 334 units of LGND stock worth 40,247$ on 18 May 2016.
The largest trade Melanie's ever made was exercising 7,719 units of Ligand Pharmaceuticals stock on 11 November 2015 worth over 365,032$. On average, Melanie trades about 991 units every 47 days since 2014. As of 18 May 2016 Melanie still owns at least 3,297 units of Ligand Pharmaceuticals stock.
You can see the complete history of Melanie Herman stock trades at the bottom of the page.
Melanie's mailing address filed with the SEC is 11119 NORTH TORREY PINES ROAD, SUITE 200, , LA JOLLA, CA, 92037.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over 205,340,014$ worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth 27,601,439$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of 2,239,733$. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth 50,090$.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: